Stanley Fayn

7PUBLICATIONS
59CO-AUTHORS
Molecular targetsPredictive and prognostic markersGlycoconjugatesAnimal physiological ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 25, 2026
Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathway.

|Dec 15, 2025
Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for Radiotheranostics.

Philip Homan, Joon-Yong Chung, Woonghee Lee

|Oct 17, 2025
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PET.

Stanley Fayn, Woonghee Lee, Falguni Basuli

|Sep 26, 2025
Biodistribution-Driven Discovery Identifies a Glycosidase-Cleavable Linker to Reprogram Radiotheranostics.

Woonghee Lee, Sai Reddy Doda, Kwamena E Baidoo

|Feb 18, 2025
Generation of Site-Specifically Labeled Affinity Reagents via Use of a Self-Labeling Single Domain Antibody.

Stanley Fayn, Swarnali Roy, Chino C Cabalteja

|Feb 06, 2025
Evaluation of VLA-4 (Integrin α4β1) as a Shared Target for Radiopharmaceutical Therapy across Solid Tumors.

Jeyshka M Reyes-González, Harikrishnan Rajkumar, Woonghee Lee

Pageof 2

Frequent Collaborators

5 joint publications

Freddy E Escorcia

5 joint publications

Woonghee Lee

4 joint publications

Divya Nambiar

3 joint publications

Hima Makala